Clinical Trials

NCT06548490 | RECRUITING | PHASE2
200 participants

GLP-1R Agonist Treatment for Opioid Use Disorder

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-28
Start Date:
2025-01-13
Completion:
2027-04-30
Conditions
  • Opioid Use Disorder
  • Opioid Abuse and Addiction
  • Narcotic-Related Disorders
  • Substance-Related Disorders
  • Chemically-Induced Disorders
  • Mental Disorder
  • Opioid
Interventions
  • DRUG
No Results Yet
NCT06524960 | RECRUITING | PHASE1/PHASE2
45 participants

Denosumab for Type 1 Diabetes

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-28
Start Date:
2024-09-03
Completion:
2027-10-11
Conditions
  • Type 1 Diabetes
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT06396065 | ACTIVE_NOT_RECRUITING | PHASE3
420 participants

Phase III Study of AK112 for NSCLC Patients

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-28
Start Date:
2023-05-04
Completion:
2025-04-12
Conditions
  • Non-Squamous Non-small Cell Lung Cancer
Interventions
  • DRUG
No Results Yet
NCT06392542 | NOT_YET_RECRUITING | NA
107 participants

Whole Selves User Testing and Feasibility Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-28
Start Date:
2027-09-30
Completion:
2029-09-30
Conditions
  • Alcohol Use, Unspecified
  • Relationship, Social
  • Depression, Anxiety
Interventions
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page